ENDONOVO THERAPEUTICS, INC. Note Agreements

7 Contracts & Agreements

Recent Contracts

Category

Company

Industry

Jur. Jurisdiction

Filed

Endonovo Therapeutics, Inc. 10% Senior Secured Convertible Redeemable Note Due November 30, 2019 (Eagle Equities, LLC)

Note Agreements

ENDONOVO THERAPEUTICS, INC.

Biotechnology

2018

Endonovo Therapeutics, Inc. 10% Convertible Secured Redeemable Note Due December 21, 2018 (Eagle Equities, LLC)

Note Agreements

ENDONOVO THERAPEUTICS, INC.

Biotechnology

2017

Endonovo Therapeutics, Inc. 10% Convertible Redeemable Note Due April 7, 2018 (Eagle Equities, LLC)

Note Agreements

ENDONOVO THERAPEUTICS, INC.

Biotechnology

2017

Endonovo Therapeutics, Inc. 10% Convertible Redeemable Note Due April 7, 2018 (Eagle Equities, LLC)

Note Agreements

ENDONOVO THERAPEUTICS, INC.

Biotechnology

2017

6% Senior Convertible Note between Endonovo Therapeutics, Inc. and Bellridge LP dated July 8, 2016

Note Agreements

ENDONOVO THERAPEUTICS, INC.

Biotechnology

NY

2016

Promissory Note between Endonovo Therapeutics, Inc. and Holders of Rio Grande Neurosciences, Inc. Stock Dated July 9, 2016

Note Agreements

ENDONOVO THERAPEUTICS, INC.

Biotechnology

2016

$250,000 10% Convertible Promissory Note between Endonovo Therapeutics, Inc. and Regal Consulting

Note Agreements

ENDONOVO THERAPEUTICS, INC.

Biotechnology

NV

2016